Charlotte V. N.
- Country
- The Netherlands
- Department
- Internal Medicine
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Evaluation of Levothyroxine and Liothyronine Combination Therapy Versus Levothyroxine Monotherapy in Autoimmune Hypothyroidism with Persistent Fatigue
- A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease
Data & Insights
Has run more than one trial at 65 of 117 partner sites.
Specializations
Thyroid Health Research
This investigator specializes in the study of autoimmune hypothyroidism and its treatment modalities, with particular attention to improving patient outcomes in cases of persistent symptoms.
- Thyroid Hormone Therapy Optimization
- Treatment-Resistant Hypothyroidism
- Combination Therapy Approaches
The research focus includes evaluating different therapeutic strategies for managing persistent thyroid-related fatigue.
Genetic Medicine Applications
The investigator explores the relationship between genetic variations and treatment responses in thyroid disorders, particularly focusing on deiodinase and monocarboxylate transporter genes.
- Personalized Medicine Approaches
- Genetic Markers in Treatment Response
- Transport Protein Studies
Research extends to understanding how genetic factors influence individual responses to thyroid hormone replacement therapy.
Quality of Life Studies
The investigator examines the impact of various treatment approaches on patient quality of life, with specific attention to managing persistent tiredness in hypothyroid patients.
- Symptom Management
- Patient-Reported Outcomes
- Treatment Effectiveness Measures
The research encompasses long-term monitoring of therapeutic interventions and their effects on daily patient functioning.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.